İçeriğe geç
akaturk Akademik ölçüm
Giriş Kayıt

Akademisyen

SUNA YAPALI

DOÇENT

ACIBADEM MEHMET ALİ AYDINLAR ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ

  • Ana Dal Sağlık Bilimleri Temel Alanı
  • Yan Dal Gastroenteroloji (İç Hastalıkları)

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

  • Makale 85
  • Proje 0
  • Kitap 1
  • Bildiri 118
  • Patent 0
  • Sanatsal 0
Scopus (SJR) Q1 43 Q2 18 Q3 12 Q4 6
WoS (JCR) Q1 39 Q2 6 Q3 20 Q4 16
TR Index 12 makale

Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.

Üst %1 makale 0
Üst %10 makale 15
Ort. yüzdelik 71.2%
Üst %1 payı 0.0%
Üst %10 payı 21.7%

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Dizin filtreleri

Toplam 85 yayın

Scopus (SJR)
Q1 43 Q2 18 Q3 12 Q4 6
WoS (JCR)
Q1 39 Q2 6 Q3 20 Q4 16
TR Index
12 makale

Makale listesi

  1. 2025 Psychological and Clinical Factors Mediate Post‐COVID‐19 Irritable Bowel Syndrome Neurogastroenterology & Motility DOI 10.1111/nmo.70079 YÖKSİS SJR Q1 JCR Q2 OpenAlex 88.6%
  2. 2025 Psychological and Clinical Factors Mediate Post‐COVID‐19 Irritable Bowel Syndrome Neurogastroenterology & Motility DOI 10.1111/nmo.70079 YÖKSİS SJR Q1 JCR Q2 OpenAlex 88.3%
  3. 2025 Neural-Mediated Laryngopharyngeal Reflux Disease and the Role of Esophageal Dysmotility Otolaryngologic Clinics of North America DOI 10.1016/j.otc.2025.01.003 YÖKSİS SJR Q2 JCR Q2 OpenAlex 87.1%
  4. 2025 Long‐Term Impact of COVID‐19 on Disorders of Gut–Brain Interaction: Incidence, Symptom Burden, and Psychological Comorbidities United European Gastroenterology Journal DOI 10.1002/ueg2.70005 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 95.4%
  5. 2025 Long‐Term Impact of COVID‐19 on Disorders of Gut–Brain Interaction: Incidence, Symptom Burden, and Psychological Comorbidities United European Gastroenterology Journal DOI 10.1002/ueg2.70005 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 95.4%
  6. 2025 Long‐Term Impact of COVID‐19 on Disorders of Gut–Brain Interaction: Incidence, Symptom Burden, and Psychological Comorbidities United European Gastroenterology Journal DOI 10.1002/ueg2.70005 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 95.4%
  7. 2025 Long‐Term Impact of COVID‐19 on Disorders of Gut–Brain Interaction: Incidence, Symptom Burden, and Psychological Comorbidities United European Gastroenterology Journal DOI 10.1002/ueg2.70005 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 95.4%
  8. 2025 Psychological and Clinical Factors Mediate Post‐COVID‐19 Irritable Bowel Syndrome Neurogastroenterology & Motility DOI 10.1111/nmo.70079 YÖKSİS SJR Q1 JCR Q2 OpenAlex 88.3%
  9. 2025 Long‐Term Impact of COVID‐19 on Disorders of Gut–Brain Interaction: Incidence, Symptom Burden, and Psychological Comorbidities United European Gastroenterology Journal DOI 10.1002/ueg2.70005 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 95.4%
  10. 2025 Efficacy and tolerability of tenofovir alafenamide fumarate prophylaxis in HBV-infected individuals receiving chemo/ immunosuppressive therapy Hepatol Forum. YÖKSİS TR Index SJR Q3 JCR Q3
  11. 2025 Psychological and Clinical Factors Mediate Post-COVID-19 Irritable Bowel Syndrome NEUROGASTROENTEROLOGY AND MOTILITY DOI 10.1111/nmo.70079 YÖKSİS SJR Q1 JCR Q2 OpenAlex 88.6%
  12. 2023 Safety and Effectiveness of Tenofovir Alafenamide in the Turkish Population: A Systematic Review Galenos Yayinevi DOI 10.4274/VHD.GALENOS.2023.2023-8-3 YÖKSİS SJR Q4 JCR Q4 OpenAlex 6.4%
  13. 2023 Post COVID-19 irritable bowel syndrome Gut DOI 10.1136/gutjnl-2022-328483 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 98.7%
  14. 2023 Post COVID-19 irritable bowel syndrome Gut DOI 10.1136/gutjnl-2022-328483 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 98.7%
  15. 2023 TASL Practice Guidance on the Clinical Assessment and Management of Patients with Nonalcoholic Fatty Liver Disease Kare Publishing (Hepatology Forum) DOI 10.14744/hf.2023.2023.0011 YÖKSİS TR Index SJR Q3 JCR Q4 OpenAlex 89.4%
  16. 2023 Post COVID-19 irritable bowel syndrome Gut DOI 10.1136/gutjnl-2022-328483 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 98.7%
  17. 2023 TASL Practice Guidance on the Clinical Assessment and Management of Patients with Nonalcoholic Fatty Liver Disease Kare Publishing DOI 10.14744/hf.2023.2023.0011 YÖKSİS TR Index SJR Q3 JCR Q4 OpenAlex 89.4%
  18. 2023 Safety and Effectiveness of Tenofovir Alafenamide in the Turkish Population: A Systematic Review Viral Hepatitis Journal DOI 10.4274/vhd.galenos.2023.2023-8-3 YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 6.4%
  19. 2022 Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study American Journal of Gastroenterology DOI 10.14309/ajg.0000000000001541 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 92.3%
  20. 2022 SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis Journal of Autoimmunity DOI 10.1016/j.jaut.2022.102906 YÖKSİS SJR Q1 JCR Q1 OpenAlex 87.3%

Akademisyenlere dön